H. Samonigg

Centre Léon Bérard — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index4.2kcitations136works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(28), Cancer Treatment and Pharmacology(25), Advanced Breast Cancer Therapies(15), Estrogen and related hormone effects(13), Colorectal Cancer Treatments and Studies(13)

Publications133 total

The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
British Journal of Cancer·2015· 73 citedOpen Access
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy
The Pharmacogenomics Journal·2015· 14 citedOpen Access
Evaluation of Soluble E-Cadherin as a Predictive Marker for Response to Preoperative Systemic Chemotherapy in Early Breast Cancer
Annals of Oncology·2014Open Access
An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients
Annals of Oncology·2013· 43 citedOpen Access
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
British Journal of Cancer·2013· 320 citedOpen Access
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
Annals of Oncology·2013· 65 citedOpen Access
Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients
British Journal of Cancer·2013· 185 citedOpen Access
Cost of Cancer in the Austrian Hospital Setting
Value in Health·2013
Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients
British Journal of Cancer·2013· 84 citedOpen Access
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial
British Journal of Cancer·2013· 58 citedOpen Access
A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
British Journal of Cancer·2013· 227 citedOpen Access
The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy
Clinical Biochemistry·2013· 21 cited
Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma
British Journal of Cancer·2013· 23 citedOpen Access
The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy
The Pharmacogenomics Journal·2013· 21 cited
Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients
British Journal of Cancer·2013· 154 citedOpen Access
Efficacy of tamoxifen±aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
British Journal of Cancer·2013· 26 citedOpen Access
Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival
British Journal of Cancer·2012· 40 citedOpen Access
Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer
British Journal of Cancer·2012· 90 citedOpen Access
Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.
Journal of Clinical Oncology·2011· 4 cited
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck
British Journal of Cancer·2011· 17 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Michael Gnant(16), R. Jakesz(15), Armin Gerger(10), E. Kubista(9), Richard Greil(9), Herbert Stöger(9), Michael Stotz(8), Martin Pichler(8), Joanna Szkandera(7), W. Kwasny(7), Brigitte Mlineritsch(7), M. Stierer(7), H. Hausmaninger(7), Gudrun Absenger(6), Tatjana Stojaković(6), Renate Schaberl-Moser(5), Marianne Schmid(5), Guenther G. Steger(5), F Hofbauer(4), Michael Fridrik(4)